Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FAM210B mRNA] | CTD | PMID:31150632 | (1->4)-beta-D-glucan | multiple interactions | ISO | Fam210b (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FAM210B mRNA | CTD | PMID:36331819 | 17beta-estradiol | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of FAM210B mRNA | CTD | PMID:30165855 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FAM210B mRNA | CTD | PMID:32109520 and PMID:33387578 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FAM210B mRNA | CTD | PMID:28628672 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of FAM210B mRNA | CTD | PMID:24780913 | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of FAM210B mRNA | CTD | PMID:31881176 | acrylamide | decreases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of FAM210B mRNA | CTD | PMID:32763439 | aflatoxin B1 | increases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of FAM210B mRNA | CTD | PMID:21641981 | all-trans-retinoic acid | decreases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of FAM210B mRNA | CTD | PMID:33167477 | antirheumatic drug | increases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of FAM210B mRNA | CTD | PMID:24449571 | arsenite(3-) | increases methylation | ISO | FAM210B (Homo sapiens) | 6480464 | arsenite results in increased methylation of FAM210B promoter | CTD | PMID:23974009 | arsenite(3-) | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to FAM210B mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | increases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of FAM210B mRNA | CTD | PMID:21871943 and PMID:26238291 | benzo[a]pyrene | decreases methylation | ISO | FAM210B (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of FAM210B promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | Fam210b (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of FAM210B promoter | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | increases expression | ISO | FAM210B (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:26238291 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of FAM210B mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | FAM210B (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of FAM210B mRNA | CTD | PMID:33670352 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of FAM210B mRNA | CTD | PMID:32145629 | bisphenol A | increases expression | ISO | Fam210b (Mus musculus) | 6480464 | bisphenol A results in increased expression of FAM210B mRNA | CTD | PMID:30951980 and PMID:34585602 | bisphenol A | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FAM210B mRNA | CTD | PMID:28628672 | Bisphenol B | increases expression | ISO | FAM210B (Homo sapiens) | 6480464 | bisphenol B results in increased expression of FAM210B protein | CTD | PMID:34186270 | bisphenol F | increases expression | ISO | Fam210b (Mus musculus) | 6480464 | bisphenol F results in increased expression of FAM210B mRNA | CTD | PMID:30951980 | cadmium dichloride | decreases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of FAM210B mRNA | CTD | PMID:25596134 | carbamazepine | affects expression | ISO | FAM210B (Homo sapiens) | 6480464 | Carbamazepine affects the expression of FAM210B mRNA | CTD | PMID:25979313 | carbon nanotube | increases expression | ISO | Fam210b (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of FAM210B mRNA | CTD | PMID:25554681 | chloroacetaldehyde | affects expression | ISO | FAM210B (Homo sapiens) | 6480464 | chloroacetaldehyde affects the expression of FAM210B mRNA | CTD | PMID:25596134 | cidofovir anhydrous | increases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Cidofovir results in increased expression of FAM210B mRNA | CTD | PMID:25596134 | cisplatin | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of FAM210B mRNA | CTD | PMID:27392435 | cisplatin | increases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Cisplatin results in increased expression of FAM210B mRNA | CTD | PMID:27392435 | cobalt dichloride | decreases expression | ISO | FAM210B (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of FAM210B mRNA | CTD | PMID:19320972 | copper(II) sulfate | decreases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of FAM210B mRNA | CTD | PMID:19549813 | coumestrol | decreases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Coumestrol results in decreased expression of FAM210B mRNA | CTD | PMID:19167446 | cyclosporin A | decreases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of FAM210B mRNA | CTD | PMID:20106945 more ... | daidzein | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of FAM210B mRNA | CTD | PMID:27424125 | daidzein 7-O-beta-D-glucoside | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of FAM210B mRNA | CTD | PMID:27424125 | dexamethasone | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FAM210B mRNA | CTD | PMID:28628672 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of FAM210B mRNA | CTD | PMID:21266533 | dicrotophos | decreases expression | ISO | FAM210B (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of FAM210B mRNA | CTD | PMID:28302478 | dimethylarsinous acid | decreases expression | ISO | FAM210B (Homo sapiens) | 6480464 | dimethylarsinous acid results in decreased expression of FAM210B mRNA | CTD | PMID:23487506 | dioxygen | decreases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of FAM210B mRNA | CTD | PMID:25596134 | dorsomorphin | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | entinostat | increases expression | ISO | FAM210B (Homo sapiens) | 6480464 | entinostat results in increased expression of FAM210B mRNA | CTD | PMID:27188386 | ethyl methanesulfonate | increases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of FAM210B mRNA | CTD | PMID:23649840 | fipronil | increases expression | EXP | | 6480464 | fipronil results in increased expression of FAM210B mRNA | CTD | PMID:23962444 | genistein | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of FAM210B mRNA | CTD | PMID:27424125 | genistein 7-O-beta-D-glucoside | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of FAM210B mRNA | CTD | PMID:27424125 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of FAM210B mRNA | CTD | PMID:33387578 | glafenine | decreases expression | EXP | | 6480464 | Glafenine results in decreased expression of FAM210B mRNA | CTD | PMID:24136188 | glycitein | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of FAM210B mRNA | CTD | PMID:27424125 | glycitin | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of FAM210B mRNA | CTD | PMID:27424125 | hydralazine | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of FAM210B mRNA | CTD | PMID:17183730 | ibuprofen | decreases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Ibuprofen results in decreased expression of FAM210B mRNA | CTD | PMID:25596134 | ifosfamide | decreases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Ifosfamide results in decreased expression of FAM210B mRNA | CTD | PMID:25596134 | indometacin | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FAM210B mRNA | CTD | PMID:28628672 | inulin | multiple interactions | ISO | Fam210b (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FAM210B mRNA | CTD | PMID:36331819 | lipopolysaccharide | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | lipopolysaccharide | decreases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of FAM210B mRNA | CTD | PMID:35811015 | manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of FAM210B mRNA | CTD | PMID:28801915 | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of FAM210B mRNA | CTD | PMID:28801915 | nickel atom | decreases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Nickel results in decreased expression of FAM210B mRNA | CTD | PMID:25583101 | nitrofen | decreases expression | EXP | | 6480464 | nitrofen results in decreased expression of FAM210B mRNA | CTD | PMID:26720608 | oxaliplatin | decreases expression | EXP | | 6480464 | oxaliplatin results in decreased expression of FAM210B mRNA | CTD | PMID:25729387 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of FAM210B mRNA | CTD | PMID:25729387 | paracetamol | increases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of FAM210B mRNA | CTD | PMID:22230336 | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of FAM210B mRNA | CTD | PMID:32680482 | perfluorohexanesulfonic acid | increases expression | ISO | Fam210b (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of FAM210B mRNA | CTD | PMID:37995155 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Fam210b (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FAM210B mRNA more ... | CTD | PMID:36331819 | perfluorooctanoic acid | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of FAM210B mRNA | CTD | PMID:33325755 | phenobarbital | affects expression | ISO | Fam210b (Mus musculus) | 6480464 | Phenobarbital affects the expression of FAM210B mRNA | CTD | PMID:23091169 | phenylmercury acetate | increases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of FAM210B mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM210B mRNA | CTD | PMID:27188386 | phytoestrogen | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of FAM210B mRNA | CTD | PMID:33325755 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of FAM210B mRNA | CTD | PMID:28374803 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | decreases expression | ISO | Fam210b (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of FAM210B mRNA | CTD | PMID:37682722 | sunitinib | decreases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of FAM210B mRNA | CTD | PMID:31533062 | temozolomide | decreases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of FAM210B mRNA | CTD | PMID:31758290 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of FAM210B mRNA | CTD | PMID:31150632 | tetrachloromethane | decreases expression | ISO | Fam210b (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of FAM210B mRNA | CTD | PMID:31919559 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FAM210B mRNA] | CTD | PMID:31150632 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of FAM210B mRNA | CTD | PMID:23411599 and PMID:34492290 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of FAM210B mRNA | CTD | PMID:25729387 | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of FAM210B mRNA | CTD | PMID:25729387 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of FAM210B mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | FAM210B (Homo sapiens) | 6480464 | trichostatin A results in increased expression of FAM210B mRNA | CTD | PMID:26272509 | trichostatin A | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM210B mRNA | CTD | PMID:27188386 | Triptolide | increases expression | EXP | | 6480464 | triptolide results in increased expression of FAM210B protein | CTD | PMID:32519852 | tunicamycin | decreases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Tunicamycin results in decreased expression of FAM210B mRNA | CTD | PMID:22378314 | urethane | decreases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Urethane results in decreased expression of FAM210B mRNA | CTD | PMID:28818685 | valdecoxib | decreases expression | EXP | | 6480464 | valdecoxib results in decreased expression of FAM210B mRNA | CTD | PMID:24136188 | valproic acid | multiple interactions | ISO | FAM210B (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of FAM210B mRNA | CTD | PMID:17183730 | valproic acid | affects expression | ISO | FAM210B (Homo sapiens) | 6480464 | Valproic Acid affects the expression of FAM210B mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | FAM210B (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of FAM210B mRNA | CTD | PMID:23179753 more ... | |